Drug Trial Radar · NCT02395978
A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Last checked: Nov 20, 2026Latest source record: Jul 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
72
Actual
Start
Apr 10, 2015
Primary completion
Mar 12, 2019
Study completion Mar 18, 2019
Sponsor
- Lead sponsor
- BioLite, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 24, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy in patients with major depressive disorder.
Conditions
- Major Depressive Disorder
Interventions
PDC-1421 CapsuleDrug
PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as active ingredient.
placeboDrug
Placebo contained corn starch.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of Montgomery-Asberg Depression Rating Scale (MADRS) Total Score From Baseline to Week 6 Compared to Placebo for Part II.Time frame: From Baseline to Week 6
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Stanford Depression Research Clinic
San Francisco, California
Taipei Veterans General Hospital
Taipei, Taiwan
Tri-Service General Hospital, Neihu Main Facility
Taipei, Taiwan
Wan Fang Hospital
Taipei, Taiwan
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.